Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

BACKGROUND AND OBJECTIVES: Myasthenia gravis (MG) is an autoimmune disease characterized by dysfunction at the neuromuscular junction. Treatment frequently includes corticosteroids (CSs) and IV immunoglobulin (IVIG). This study was conducted to determine whether immune globulin (human), 10% caprylat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bril, Vera, Szczudlik, Andrzej, Vaitkus, Antanas, Rozsa, Csilla, Kostera-Pruszczyk, Anna, Hon, Petr, Bednarik, Josef, Tyblova, Michaela, Köhler, Wolfgang, Toomsoo, Toomas, Nowak, Richard J., Mozaffar, Tahseen, Freimer, Miriam L., Nicolle, Michael W., Magnus, Tim, Pulley, Michael T., Rivner, Michael, Dimachkie, Mazen M., Distad, B. Jane, Pascuzzi, Robert M., Babiar, Donna, Lin, Jiang, Querolt Coll, Montse, Griffin, Rhonda, Mondou, Elsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969924/
https://www.ncbi.nlm.nih.gov/pubmed/36270895
http://dx.doi.org/10.1212/WNL.0000000000201501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969924/
https://www.ncbi.nlm.nih.gov/pubmed/36270895
http://dx.doi.org/10.1212/WNL.0000000000201501

Ejemplares similares